Table 5.
Survival Outcomes
| N=95 | % | |
|---|---|---|
| Median Overall Survival, months(m), (95%CI) | ||
| After cancer diagnosis | 12.3m (10.2–14.4) | |
| After 1st thrombosis diagnosed | 4.3m (3–5.6) | |
| Median months to develop first VT | 1.9m (0.8–2.8) | |
| Bleeding complication while on systemic anticoagulation1 | 8 | 8.4 |
| Death from other cause during hospital admission | 15 | 15 |
| Death secondary to thromboses during a hospital admission | 3 | 3 |
| Time in months from PDAC diagnosis to 1st VT presentation, median 1.8m (range 0.8m–2.8m) | ||
| 0–2 | 55 (0.7) | 58 |
| 3–5 | 16 (3.7) | 17 |
| 6–8 | 5 (6.6) | 5 |
| 9–11 | 6 (9.5) | 6 |
| >12 | 13 (17.2) | 14 |
| Time in months from diagnosis of 1st VT to death, median 4.3m (range 3m–5.57m) | ||
| 0–2 | 32(1.1) | 34 |
| 3–5 | 20(4.2) | 21 |
| 6–8 | 13(6.8) | 14 |
| 9–11 | 6(10) | 6 |
| >12 | 17(15.6) | 18 |
| Patients still alive by 03/2017 | N=3 | 7 |
| Median OS by VT location (months), (95%CI) | ||
| Portal vein | 3.6 (2.3–4.8) | |
| Mesenteric vein | 7.4(1.5–13.4) | |
| Splenic Vein | 5.7(0–13) | |
| Renal Vein | 10(1.6–18.3) | |
| Gonadal Vein | 5.8 (4.2–7.4) |
1.
Gastrointestinal bleeding, hemorrhagic stroke, intraabdominal bleeding